Sweden · Delayed Price · Currency is SEK SynAct Pharma AB Statistics
Total Valuation
STO:SYNACT has a market cap or net worth of SEK 1.08 billion. The enterprise value is 1.02 billion.
| Market Cap | 1.08B |
| Enterprise Value | 1.02B |
Important Dates
The next confirmed earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:SYNACT has 56.00 million shares outstanding. The number of shares has increased by 22.00% in one year.
| Current Share Class | 56.00M |
| Shares Outstanding | 56.00M |
| Shares Change (YoY) | +22.00% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 14.03% |
| Owned by Institutions (%) | 16.03% |
| Float | 31.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 20.71 |
| PS Ratio | n/a |
| PB Ratio | 5.58 |
| P/TBV Ratio | 5.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.74, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.74 |
| Quick Ratio | 5.61 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.55% and return on invested capital (ROIC) is -39.31%.
| Return on Equity (ROE) | -59.55% |
| Return on Assets (ROA) | -32.48% |
| Return on Invested Capital (ROIC) | -39.31% |
| Return on Capital Employed (ROCE) | -52.38% |
| Weighted Average Cost of Capital (WACC) | 8.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -13.95M |
| Employee Count | 8 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.58M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.05% in the last 52 weeks. The beta is 0.75, so STO:SYNACT's price volatility has been lower than the market average.
| Beta (5Y) | 0.75 |
| 52-Week Price Change | +1.05% |
| 50-Day Moving Average | 17.30 |
| 200-Day Moving Average | 18.88 |
| Relative Strength Index (RSI) | 55.98 |
| Average Volume (20 Days) | 163,404 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -118.75M |
| Pretax Income | -119.21M |
| Net Income | -111.63M |
| EBITDA | -116.79M |
| EBIT | -116.79M |
| Earnings Per Share (EPS) | -2.14 |
Balance Sheet
The company has 65.78 million in cash and 1.07 million in debt, with a net cash position of 64.71 million or 1.16 per share.
| Cash & Cash Equivalents | 65.78M |
| Total Debt | 1.07M |
| Net Cash | 64.71M |
| Net Cash Per Share | 1.16 |
| Equity (Book Value) | 193.74M |
| Book Value Per Share | 3.46 |
| Working Capital | 70.62M |
Cash Flow
| Operating Cash Flow | -101.46M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 627,000 |
| Net Borrowing | -576,000 |
| Free Cash Flow | -97.33M |
| FCF Per Share | -1.74 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:SYNACT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.00% |
| Shareholder Yield | -22.00% |
| Earnings Yield | -10.33% |
| FCF Yield | -9.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |